No phaseRecruitingAge-related condition

Radiofrequency or vaginal moisturizer for vaginal symptoms in breast cancer survivors

Fractional microablative radiofrequency versus vaginal moisturizer in breast cancer survivors with genitourinary syndrome: a pilot study - RF-GSM Radiofrequency in Genitourinary Syndrome of Menopause

Sponsor
Fundação Oswaldo Cruz (Fiocruz)
Enrolment
60 planned
Conditions
Vaginal Diseases; Dyspareunia; Breast Neoplasms Menopause; G08.686.157.500
Interventions
a total of 60 participants will be allocated in a one to one ratio by simple randomization, with 30 in the intervention group and 30 in the comparator group; the comparator group, with 30 participants, will use an intravaginal hyaluronic acid-based moisturizing gel three times per week until the end of the study; the total duration of the intervention will be up to 18 weeks, with assessments carried out at four visits
Ages
adults, older adults
Registry
RBR-10gzp5hq

Full record on ReBECSource: WHO ICTRP, processed 14 September 2026

Primary outcomes

  • Improvement in self-reported vulvovaginal symptoms is expected in both groups and will be assessed and compared between the intervention group and the comparator group by means of the Vaginal Assessment Scale and the Vulvar Assessment Scale, whose scores measure the severity of vaginal and vulvar sy

History

  1. Study completion expected

  2. Last registry update

  3. Started

  4. Registered